Related Experiment Video

Updated: Jul 15, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
05:53

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates

Published on: July 6, 2013

Cytomegalovirus in transplantation - challenging the status quo

Jay A Fishman1, Vincent Emery, Richard Freeman

  • 1Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Clinical Transplantation
|April 12, 2007
PubMed
Abstract

Insights

Cytomegalovirus (CMV) prophylaxis in solid organ transplant recipients improves survival and prevents complications. Universal prophylaxis is more cost-effective than pre-emptive therapy, though optimal regimens require further study.

Area of Science:

  • Transplant medicine
  • Infectious diseases
  • Virology

Background:

  • Cytomegalovirus (CMV) infection poses significant risks to solid organ transplant (SOT) recipients, leading to direct and indirect effects like allograft rejection and reduced survival.
  • Current CMV prevention strategies include pre-emptive therapy and universal prophylaxis, each with distinct efficacy, cost, and toxicity profiles.
  • Established standards of care for CMV prophylaxis in SOT recipients are lacking.

Purpose of the Study:

  • To review available data on Cytomegalovirus (CMV) prophylaxis strategies in solid organ transplant (SOT) recipients.
  • To compare the efficacy, costs, and side effects of pre-emptive therapy versus universal prophylaxis for CMV infection.
  • To inform the development of optimal CMV prophylaxis regimens for SOT patients.

Main Methods:

  • A committee of international experts convened to analyze existing research on CMV prophylaxis.
  • Systematic review and meta-analysis of studies comparing different CMV preventative strategies in SOT recipients.
  • Evaluation of clinical outcomes, mortality rates, and economic factors associated with CMV prevention.

Main Results:

  • Universal prophylaxis demonstrates advantages in suppressing asymptomatic viremia and preventing direct/indirect CMV effects, leading to decreased mortality.
  • While pre-emptive therapy involves frequent monitoring and treatment costs, universal prophylaxis may incur higher drug toxicity and costs.
  • Meta-analyses indicate that CMV prophylaxis is associated with reduced patient mortality and is more cost-effective than routine monitoring and pre-emptive therapy.
  • Extended prophylaxis may benefit high-risk patient groups, including specific renal, lung, and heart transplant recipients.

Conclusions:

  • CMV prophylaxis is crucial for improving allograft and patient survival in transplant recipients by mitigating direct and indirect CMV infection effects.
  • Further research is essential to define optimal prophylaxis regimens, including duration and drug selection, for various SOT populations.

More Related Videos

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus11:18

Expanding Cytotoxic T Lymphocytes from Umbilical Cord Blood that Target Cytomegalovirus, Epstein-Barr Virus, and Adenovirus

Published on: May 7, 2012

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System10:24

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...